Home
Syntara Limited
Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor
Business
Oct 11 2018
4 min read

Positive Phase 1 Results of Phase 1 Study - LOXL2 Inhibitor

news images

Syntara Limited has released a press release.

View Attachment

Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren